Showing results (31-40 of 36) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Scientific Reports|April 8, 2017
Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6Morten Ruhwald, Lena de Thurah, Davis Kuchaka, et al.Frontiers in Immunology|October 17, 2018
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment EfficacyMohamed I M Ahmed, Nyanda E Ntinginya, Gibson Kibiki, et al.Eclinicalmedicine|March 2, 2026
Aetiology of sepsis in adults living with HIV in East Africa: a secondary analysis of an open-label, multicentre, randomised, controlled phase 3 trialEva Otoupalova, Lucas Ampaire, Megan Null, et al.The Journal of Antimicrobial Chemotherapy|July 4, 2025
Cardiac safety of bedaquiline, delamanid and moxifloxacin co-administered with or without varying doses of sutezolid or delpazolid for the treatment of drug-susceptible TBSimon E Koele, Krista Stoycheva, Cyprian Mtweve, et al.The Lancet. Infectious Diseases|July 11, 2025
Sutezolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-SUDOCU-01): a prospective, open-label, randomised, phase 2b dose-finding trialNorbert Heinrich, Christina Manyama, Simon E Koele, et al.The Lancet. Infectious Diseases|July 11, 2025
Delpazolid in combination with bedaquiline, delamanid, and moxifloxacin for pulmonary tuberculosis (PanACEA-DECODE-01): a prospective, randomised, open-label, phase 2b, dose-finding trialLilian Tina Minja, Isabella van der Feltz, Christina Manyama, et al.Pageof 4